1A14 image
Entry Detail
PDB ID:
1A14
Title:
COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 5 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
Biological Source:
Host Organism:
PDB Version:
Deposition Date:
1997-12-21
Release Date:
1998-05-13
Method Details:
Experimental Method:
Resolution:
2.50 Å
R-Value Free:
0.27
R-Value Work:
0.2
R-Value Observed:
0.2
Space Group:
I 4 2 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:NC10 FV (HEAVY CHAIN)
Chain IDs:B (auth: H)
Chain Length:120
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:NC10 FV (LIGHT CHAIN)
Chain IDs:C (auth: L)
Chain Length:104
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:NEURAMINIDASE
Chain IDs:A (auth: N)
Chain Length:388
Number of Molecules:1
Biological Source:Influenza A virus
Modified Residue
Compound ID Chain ID Parent Comp ID Details 2D Image
ASN A ASN GLYCOSYLATION SITE
Primary Citation
Three-dimensional structures of single-chain Fv-neuraminidase complexes.
J.Mol.Biol. 279 901 910 (1998)
PMID: 9642070 DOI: 10.1006/jmbi.1998.1794

Abstact

The structure of the complex between a recombinant single-chain Fv construct of antibody NC10 with a five-residue peptide linker between VH and VL (termed scFv(5)), and its antigen, tetrameric neuraminidase from influenza virus (NA), has been determined and refined at 2.5 A resolution. The antibody-antigen binding interface is very similar to that of a similar NC10 scFv-NA complex in which the scFv has a 15-residue peptide linker (scFv(15)), and the NC10 Fab-NA complex. However, scFv(5) and scFv(15) have different stoichiometries in solution. While scFv(15) is predominantly monomeric in solution, scFv(5) forms dimers exclusively, because the five-residue linker is not long enough to permit VH and VL domains from the same polypeptide associating and forming an antigen-binding site. Upon forming a complex with NA, scFv(15) forms a approximately 300 kDa complex corresponding to one NA tetramer binding four scFv(15) monomers, while scFv(5) forms a approximately 590 kDa complex, corresponding to two NA tetramers crosslinked by four bivalent scFv(5) dimers. However, the dimeric scFv(5) in the scFv(5)-NA crystals does not crosslink NA tetramers, and modelling studies indicate that it is not possible to pack four dimeric and simultaneously bivalent scFvs between the NA tetramers with only a five-residue linker between VH and VL. The inability arises from the exacting requirement to orient the two antigen-binding surfaces to bind the tetrameric NA antigen while avoiding steric clashes with NC10 scFv(5) dimers bound to other sites on the NA tetramer. The utility of bivalent or bifunctional scFvs with short linkers may therefore be restricted by the steric constraints imposed by binding multivalent antigens.

Legend

Protein

Chemical

Disease

Primary Citation of related structures